We are live on ! Find out more
FMI

F/M Investments Portfolio holdings

AUM $1.51B
1-Year Est. Return 25.86%
This Fund
S&P 500
This Quarter Est. Return
+4.4%
1 Year Est. Return
+25.86%
3 Year Est. Return
+100.08%
5 Year Est. Return
+137.58%
10 Year Est. Return
AUM
$2.77B
AUM Growth
+$2.62B
Cap. Flow
+$2.56B
Cap. Flow %
92.31%
Top 10 Hldgs %
26.07%
Holding
354
New
274
Increased
32
Reduced
6
Closed
39

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$101M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$83M
3
AAPL icon
Apple
AAPL
+$75.3M
4
NVDA icon
NVIDIA
NVDA
+$72.6M
5
AMZN icon
Amazon
AMZN
+$71.1M

Sector Composition

Rank Sector Weight
1 Technology 26.44%
2 Industrials 13.03%
3 Healthcare 12.33%
4 Financials 10.77%
5 Consumer Discretionary 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FANG icon
176
Diamondback Energy
FANG
$55.9B
$4.08M 0.15%
20,351
+11,440
+128% +$2.27M
MRK icon
177
Merck
MRK
$316B
$4M 0.14%
32,326
+30,390
+1,570% +$3.91M
EPD icon
178
Enterprise Products Partners
EPD
$81.9B
$3.92M 0.14%
+135,362
New +$3.88M
GOOG icon
179
Alphabet (Google) Class C
GOOG
$4.59T
$3.61M 0.13%
19,661
+17,001
+639% +$2.89M
TSN icon
180
Tyson Foods
TSN
$20.7B
$3.57M 0.13%
+62,418
New +$3.65M
FCX icon
181
Freeport-McMoran
FCX
$91.5B
$3.56M 0.13%
+73,153
New +$3.69M
MCHP icon
182
Microchip Technology
MCHP
$40.8B
$3.55M 0.13%
+38,804
New +$3.55M
ORCL icon
183
Oracle
ORCL
$420B
$3.52M 0.13%
+24,943
New +$3.1M
ATEC icon
184
Alphatec Holdings
ATEC
$1.56B
$3.28M 0.12%
+314,210
New +$3.66M
SLB icon
185
SLB Ltd
SLB
$75.4B
$3.26M 0.12%
+69,017
New +$3.33M
MDT icon
186
Medtronic
MDT
$111B
$3.25M 0.12%
+41,425
New +$3.4M
VNQ icon
187
Vanguard Real Estate ETF
VNQ
$39.2B
$3.16M 0.11%
+37,698
New +$3.11M
VIOO icon
188
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.29B
$3.05M 0.11%
+31,054
New +$3.05M
WBS icon
189
Webster Financial
WBS
$12.6B
$2.98M 0.11%
+68,478
New +$3.05M
NUE icon
190
Nucor
NUE
$62.4B
$2.93M 0.11%
+18,520
New +$3.22M
DT icon
191
Dynatrace
DT
$12.9B
$2.88M 0.1%
+64,445
New +$2.97M
ZHOG
192
F/M Opportunistic Income ETF
ZHOG
$46.5M
$2.74M 0.1%
+53,200
New +$2.72M
TFC icon
193
Truist Financial
TFC
$64.3B
$2.64M 0.1%
+68,267
New +$2.58M
PNC icon
194
PNC Financial Services
PNC
$101B
$2.62M 0.09%
+16,805
New +$2.6M
BFC icon
195
Bank First Corp
BFC
$1.72B
$2.56M 0.09%
+31,000
New +$2.5M
TJX icon
196
TJX Companies
TJX
$174B
$2.5M 0.09%
22,745
+20,598
+959% +$2.07M
PFE icon
197
Pfizer
PFE
$145B
$2.46M 0.09%
+87,899
New +$2.42M
EMN icon
198
Eastman Chemical
EMN
$8.23B
$2.43M 0.09%
+24,928
New +$2.47M
MMM icon
199
3M
MMM
$91.4B
$2.28M 0.08%
22,338
+19,879
+808% +$1.94M
IBND icon
200
State Street SPDR Bloomberg International Corporate Bond ETF
IBND
$461M
$2.24M 0.08%
+78,112
New +$2.25M

Similar funds

F/M Investments's Q2 2024 Portfolio in Review

As of Q2 2024, F/M Investments held 354 positions worth $2.77B, up 1,770% from $148M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

F/M Investments deployed $2.56B of net new capital in Q2 2024, opening 274 new positions and adding to 32 existing holdings. Its largest new stake was Eli Lilly: 47,511 shares worth $43M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 38% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $1.21M trimmed.

  • F/M Investments's largest Q2 2024 buy was Eli Lilly: 47,511 shares worth $43M.
  • F/M Investments added most to Microsoft in Q2 2024, an estimated $101M increase.
  • F/M Investments's biggest Q2 2024 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.21M.
  • F/M Investments fully exited F/M 10-Year Investment Grade Corporate Bond ETF in Q2 2024, selling an estimated $11.6M.
  • F/M Investments's ten largest holdings make up 26% of its $2.77B portfolio in Q2 2024.
  • F/M Investments opened 274 new positions and closed 39 in Q2 2024.
  • F/M Investments's portfolio value rose 1,770% quarter-over-quarter to $2.77B.

Based on F/M Investments's 13F filing for Q2 2024, filed 29 Jul 2024.